Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

Clinical trial NCT03910972 · COMPLETED

Trial details

NCT number: NCT03910972
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schistosomiasis Schistosoma Mansoni

Start date: 2019-10-07
Primary completion: 2024-11-13
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.